The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
The global Ubenimex market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ubenimex is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ubenimex is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ubenimex include Nippon Kayaku, Eiger BioPharma, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Sinopharm, Xi'an Wanlong Pharmaceutical, Sichuan Luye Pharmaceutical, Chengdu Yuandong Biopharmaceutical and Zhejiang Puluo Kangyu Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ubenimex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ubenimex.
Report Scope
The Ubenimex market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ubenimex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ubenimex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nippon Kayaku
Eiger BioPharma
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
Xi'an Wanlong Pharmaceutical
Sichuan Luye Pharmaceutical
Chengdu Yuandong Biopharmaceutical
Zhejiang Puluo Kangyu Pharmaceutical
Segment by Type
Tablets
Capsule
Segment by Application
Cancer
Edema
High Blood Pressure
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ubenimex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ubenimex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
The global Ubenimex market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ubenimex is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ubenimex is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ubenimex include Nippon Kayaku, Eiger BioPharma, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Sinopharm, Xi'an Wanlong Pharmaceutical, Sichuan Luye Pharmaceutical, Chengdu Yuandong Biopharmaceutical and Zhejiang Puluo Kangyu Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ubenimex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ubenimex.
Report Scope
The Ubenimex market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ubenimex market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ubenimex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nippon Kayaku
Eiger BioPharma
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
Xi'an Wanlong Pharmaceutical
Sichuan Luye Pharmaceutical
Chengdu Yuandong Biopharmaceutical
Zhejiang Puluo Kangyu Pharmaceutical
Segment by Type
Tablets
Capsule
Segment by Application
Cancer
Edema
High Blood Pressure
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ubenimex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ubenimex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Ubenimex Market Overview
1.1 Product Overview and Scope of Ubenimex
1.2 Ubenimex Segment by Type
1.2.1 Global Ubenimex Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.3 Ubenimex Segment by Application
1.3.1 Global Ubenimex Market Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Edema
1.3.4 High Blood Pressure
1.3.5 Other
1.4 Global Ubenimex Market Size Estimates and Forecasts
1.4.1 Global Ubenimex Revenue 2019-2030
1.4.2 Global Ubenimex Sales 2019-2030
1.4.3 Global Ubenimex Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ubenimex Market Competition by Manufacturers
2.1 Global Ubenimex Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ubenimex Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ubenimex Average Price by Manufacturers (2019-2024)
2.4 Global Ubenimex Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ubenimex, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ubenimex, Product Type & Application
2.7 Ubenimex Market Competitive Situation and Trends
2.7.1 Ubenimex Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ubenimex Players Market Share by Revenue
2.7.3 Global Ubenimex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ubenimex Retrospective Market Scenario by Region
3.1 Global Ubenimex Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ubenimex Global Ubenimex Sales by Region: 2019-2030
3.2.1 Global Ubenimex Sales by Region: 2019-2024
3.2.2 Global Ubenimex Sales by Region: 2025-2030
3.3 Global Ubenimex Global Ubenimex Revenue by Region: 2019-2030
3.3.1 Global Ubenimex Revenue by Region: 2019-2024
3.3.2 Global Ubenimex Revenue by Region: 2025-2030
3.4 North America Ubenimex Market Facts & Figures by Country
3.4.1 North America Ubenimex Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ubenimex Sales by Country (2019-2030)
3.4.3 North America Ubenimex Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ubenimex Market Facts & Figures by Country
3.5.1 Europe Ubenimex Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ubenimex Sales by Country (2019-2030)
3.5.3 Europe Ubenimex Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ubenimex Market Facts & Figures by Country
3.6.1 Asia Pacific Ubenimex Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ubenimex Sales by Country (2019-2030)
3.6.3 Asia Pacific Ubenimex Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ubenimex Market Facts & Figures by Country
3.7.1 Latin America Ubenimex Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ubenimex Sales by Country (2019-2030)
3.7.3 Latin America Ubenimex Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ubenimex Market Facts & Figures by Country
3.8.1 Middle East and Africa Ubenimex Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ubenimex Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ubenimex Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ubenimex Sales by Type (2019-2030)
4.1.1 Global Ubenimex Sales by Type (2019-2024)
4.1.2 Global Ubenimex Sales by Type (2025-2030)
4.1.3 Global Ubenimex Sales Market Share by Type (2019-2030)
4.2 Global Ubenimex Revenue by Type (2019-2030)
4.2.1 Global Ubenimex Revenue by Type (2019-2024)
4.2.2 Global Ubenimex Revenue by Type (2025-2030)
4.2.3 Global Ubenimex Revenue Market Share by Type (2019-2030)
4.3 Global Ubenimex Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ubenimex Sales by Application (2019-2030)
5.1.1 Global Ubenimex Sales by Application (2019-2024)
5.1.2 Global Ubenimex Sales by Application (2025-2030)
5.1.3 Global Ubenimex Sales Market Share by Application (2019-2030)
5.2 Global Ubenimex Revenue by Application (2019-2030)
5.2.1 Global Ubenimex Revenue by Application (2019-2024)
5.2.2 Global Ubenimex Revenue by Application (2025-2030)
5.2.3 Global Ubenimex Revenue Market Share by Application (2019-2030)
5.3 Global Ubenimex Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nippon Kayaku
6.1.1 Nippon Kayaku Corporation Information
6.1.2 Nippon Kayaku Description and Business Overview
6.1.3 Nippon Kayaku Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nippon Kayaku Ubenimex Product Portfolio
6.1.5 Nippon Kayaku Recent Developments/Updates
6.2 Eiger BioPharma
6.2.1 Eiger BioPharma Corporation Information
6.2.2 Eiger BioPharma Description and Business Overview
6.2.3 Eiger BioPharma Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eiger BioPharma Ubenimex Product Portfolio
6.2.5 Eiger BioPharma Recent Developments/Updates
6.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
6.3.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
6.3.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
6.3.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ubenimex Product Portfolio
6.3.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Corporation Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinopharm Ubenimex Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Xi'an Wanlong Pharmaceutical
6.5.1 Xi'an Wanlong Pharmaceutical Corporation Information
6.5.2 Xi'an Wanlong Pharmaceutical Description and Business Overview
6.5.3 Xi'an Wanlong Pharmaceutical Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Xi'an Wanlong Pharmaceutical Ubenimex Product Portfolio
6.5.5 Xi'an Wanlong Pharmaceutical Recent Developments/Updates
6.6 Sichuan Luye Pharmaceutical
6.6.1 Sichuan Luye Pharmaceutical Corporation Information
6.6.2 Sichuan Luye Pharmaceutical Description and Business Overview
6.6.3 Sichuan Luye Pharmaceutical Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sichuan Luye Pharmaceutical Ubenimex Product Portfolio
6.6.5 Sichuan Luye Pharmaceutical Recent Developments/Updates
6.7 Chengdu Yuandong Biopharmaceutical
6.6.1 Chengdu Yuandong Biopharmaceutical Corporation Information
6.6.2 Chengdu Yuandong Biopharmaceutical Description and Business Overview
6.6.3 Chengdu Yuandong Biopharmaceutical Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Yuandong Biopharmaceutical Ubenimex Product Portfolio
6.7.5 Chengdu Yuandong Biopharmaceutical Recent Developments/Updates
6.8 Zhejiang Puluo Kangyu Pharmaceutical
6.8.1 Zhejiang Puluo Kangyu Pharmaceutical Corporation Information
6.8.2 Zhejiang Puluo Kangyu Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Puluo Kangyu Pharmaceutical Ubenimex Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhejiang Puluo Kangyu Pharmaceutical Ubenimex Product Portfolio
6.8.5 Zhejiang Puluo Kangyu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ubenimex Industry Chain Analysis
7.2 Ubenimex Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ubenimex Production Mode & Process
7.4 Ubenimex Sales and Marketing
7.4.1 Ubenimex Sales Channels
7.4.2 Ubenimex Distributors
7.5 Ubenimex Customers
8 Ubenimex Market Dynamics
8.1 Ubenimex Industry Trends
8.2 Ubenimex Market Drivers
8.3 Ubenimex Market Challenges
8.4 Ubenimex Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ubenimex Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Ubenimex Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Ubenimex Market Competitive Situation by Manufacturers in 2023
Table 4. Global Ubenimex Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Ubenimex Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Ubenimex Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Ubenimex Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Ubenimex Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Ubenimex, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ubenimex, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ubenimex, Product Type & Application
Table 12. Global Key Manufacturers of Ubenimex, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ubenimex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ubenimex as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ubenimex Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Ubenimex Sales by Region (2019-2024) & (KG)
Table 18. Global Ubenimex Sales Market Share by Region (2019-2024)
Table 19. Global Ubenimex Sales by Region (2025-2030) & (KG)
Table 20. Global Ubenimex Sales Market Share by Region (2025-2030)
Table 21. Global Ubenimex Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Ubenimex Revenue Market Share by Region (2019-2024)
Table 23. Global Ubenimex Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Ubenimex Revenue Market Share by Region (2025-2030)
Table 25. North America Ubenimex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Ubenimex Sales by Country (2019-2024) & (KG)
Table 27. North America Ubenimex Sales by Country (2025-2030) & (KG)
Table 28. North America Ubenimex Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Ubenimex Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Ubenimex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Ubenimex Sales by Country (2019-2024) & (KG)
Table 32. Europe Ubenimex Sales by Country (2025-2030) & (KG)
Table 33. Europe Ubenimex Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Ubenimex Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Ubenimex Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Ubenimex Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Ubenimex Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Ubenimex Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Ubenimex Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ubenimex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Ubenimex Sales by Country (2019-2024) & (KG)
Table 42. Latin America Ubenimex Sales by Country (2025-2030) & (KG)
Table 43. Latin America Ubenimex Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ubenimex Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ubenimex Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Ubenimex Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Ubenimex Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Ubenimex Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Ubenimex Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Ubenimex Sales (KG) by Type (2019-2024)
Table 51. Global Ubenimex Sales (KG) by Type (2025-2030)
Table 52. Global Ubenimex Sales Market Share by Type (2019-2024)
Table 53. Global Ubenimex Sales Market Share by Type (2025-2030)
Table 54. Global Ubenimex Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Ubenimex Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Ubenimex Revenue Market Share by Type (2019-2024)
Table 57. Global Ubenimex Revenue Market Share by Type (2025-2030)
Table 58. Global Ubenimex Price (US$/G) by Type (2019-2024)
Table 59. Global Ubenimex Price (US$/G) by Type (2025-2030)
Table 60. Global Ubenimex Sales (KG) by Application (2019-2024)
Table 61. Global Ubenimex Sales (KG) by Application (2025-2030)
Table 62. Global Ubenimex Sales Market Share by Application (2019-2024)
Table 63. Global Ubenimex Sales Market Share by Application (2025-2030)
Table 64. Global Ubenimex Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Ubenimex Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Ubenimex Revenue Market Share by Application (2019-2024)
Table 67. Global Ubenimex Revenue Market Share by Application (2025-2030)
Table 68. Global Ubenimex Price (US$/G) by Application (2019-2024)
Table 69. Global Ubenimex Price (US$/G) by Application (2025-2030)
Table 70. Nippon Kayaku Corporation Information
Table 71. Nippon Kayaku Description and Business Overview
Table 72. Nippon Kayaku Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Nippon Kayaku Ubenimex Product
Table 74. Nippon Kayaku Recent Developments/Updates
Table 75. Eiger BioPharma Corporation Information
Table 76. Eiger BioPharma Description and Business Overview
Table 77. Eiger BioPharma Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Eiger BioPharma Ubenimex Product
Table 79. Eiger BioPharma Recent Developments/Updates
Table 80. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
Table 81. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Description and Business Overview
Table 82. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ubenimex Product
Table 84. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
Table 85. Sinopharm Corporation Information
Table 86. Sinopharm Description and Business Overview
Table 87. Sinopharm Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Sinopharm Ubenimex Product
Table 89. Sinopharm Recent Developments/Updates
Table 90. Xi'an Wanlong Pharmaceutical Corporation Information
Table 91. Xi'an Wanlong Pharmaceutical Description and Business Overview
Table 92. Xi'an Wanlong Pharmaceutical Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Xi'an Wanlong Pharmaceutical Ubenimex Product
Table 94. Xi'an Wanlong Pharmaceutical Recent Developments/Updates
Table 95. Sichuan Luye Pharmaceutical Corporation Information
Table 96. Sichuan Luye Pharmaceutical Description and Business Overview
Table 97. Sichuan Luye Pharmaceutical Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Sichuan Luye Pharmaceutical Ubenimex Product
Table 99. Sichuan Luye Pharmaceutical Recent Developments/Updates
Table 100. Chengdu Yuandong Biopharmaceutical Corporation Information
Table 101. Chengdu Yuandong Biopharmaceutical Description and Business Overview
Table 102. Chengdu Yuandong Biopharmaceutical Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Chengdu Yuandong Biopharmaceutical Ubenimex Product
Table 104. Chengdu Yuandong Biopharmaceutical Recent Developments/Updates
Table 105. Zhejiang Puluo Kangyu Pharmaceutical Corporation Information
Table 106. Zhejiang Puluo Kangyu Pharmaceutical Description and Business Overview
Table 107. Zhejiang Puluo Kangyu Pharmaceutical Ubenimex Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Zhejiang Puluo Kangyu Pharmaceutical Ubenimex Product
Table 109. Zhejiang Puluo Kangyu Pharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Ubenimex Distributors List
Table 113. Ubenimex Customers List
Table 114. Ubenimex Market Trends
Table 115. Ubenimex Market Drivers
Table 116. Ubenimex Market Challenges
Table 117. Ubenimex Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ubenimex
Figure 2. Global Ubenimex Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Ubenimex Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Ubenimex Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Ubenimex Market Share by Application in 2023 & 2030
Figure 8. Cancer
Figure 9. Edema
Figure 10. High Blood Pressure
Figure 11. Other
Figure 12. Global Ubenimex Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Ubenimex Market Size (2019-2030) & (US$ Million)
Figure 14. Global Ubenimex Sales (2019-2030) & (KG)
Figure 15. Global Ubenimex Average Price (US$/G) & (2019-2030)
Figure 16. Ubenimex Report Years Considered
Figure 17. Ubenimex Sales Share by Manufacturers in 2023
Figure 18. Global Ubenimex Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Ubenimex Players: Market Share by Revenue in 2023
Figure 20. Ubenimex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Ubenimex Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Ubenimex Sales Market Share by Country (2019-2030)
Figure 23. North America Ubenimex Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Ubenimex Sales Market Share by Country (2019-2030)
Figure 27. Europe Ubenimex Revenue Market Share by Country (2019-2030)
Figure 28. Germany Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Ubenimex Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Ubenimex Revenue Market Share by Region (2019-2030)
Figure 35. China Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Ubenimex Sales Market Share by Country (2019-2030)
Figure 46. Latin America Ubenimex Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Ubenimex Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Ubenimex Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Ubenimex Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Ubenimex by Type (2019-2030)
Figure 56. Global Revenue Market Share of Ubenimex by Type (2019-2030)
Figure 57. Global Ubenimex Price (US$/G) by Type (2019-2030)
Figure 58. Global Sales Market Share of Ubenimex by Application (2019-2030)
Figure 59. Global Revenue Market Share of Ubenimex by Application (2019-2030)
Figure 60. Global Ubenimex Price (US$/G) by Application (2019-2030)
Figure 61. Ubenimex Value Chain
Figure 62. Ubenimex Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
